It's thanks to your support that our researchers can continue to find new ways to prevent breast cancer, save lives and make sure people live well with and beyond the disease.
Forty years ago, only one in two women would live five years or more after a breast cancer diagnosis. Thanks to progress in research and care, it’s now almost nine in 10.
Researchers have found that a protein, frequently present in high levels in breast cancer cells, could be targeted with a new type of drug already being tested for other cancers.
New research has shown that a lifestyle programme introduced to women at a routine breast screening appointment can help lose weight and could help to reduce the risk of breast cancer.
Johnny is doing the £1,000 challenge with the aim of raising money for people like his sister, Geraldine. This is his message for anyone else who wants to get involved.
Ductal carcinoma in situ (DCIS) is an early form of breast cancer. In the UK, 7,000 people are diagnosed with DCIS every year.
We explain the different types of immunotherapy treatment for cancer patients, and what our researchers are currently working on in this area.
New research suggests that palbociclib, an already approved breast cancer drug, could help to treat triple negative breast cancer.
We report from the largest breast cancer conference in the world, the San Antonio Breast Cancer Symposium, which happened online in December 2020.